12-133202191-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003415.3(ZNF268):āc.505A>Gā(p.Lys169Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000312 in 1,603,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003415.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF268 | NM_003415.3 | c.505A>G | p.Lys169Glu | missense_variant | 6/6 | ENST00000536435.7 | NP_003406.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF268 | ENST00000536435.7 | c.505A>G | p.Lys169Glu | missense_variant | 6/6 | 1 | NM_003415.3 | ENSP00000444412.3 | ||
ENSG00000256825 | ENST00000540096.2 | c.*29A>G | 3_prime_UTR_variant | 11/11 | 2 | ENSP00000457704.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 239762Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 130026
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1450884Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 720892
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.505A>G (p.K169E) alteration is located in exon 6 (coding exon 5) of the ZNF268 gene. This alteration results from a A to G substitution at nucleotide position 505, causing the lysine (K) at amino acid position 169 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at